Related references
Note: Only part of the references are listed.Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society
Maurizio Soresi et al.
ACTA DIABETOLOGICA (2013)
Nonalcoholic fatty liver disease and serum lipoproteins: The Multi-Ethnic Study of Atherosclerosis
Andrew Paul DeFilippis et al.
ATHEROSCLEROSIS (2013)
Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7-Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism
Giovanni Musso et al.
DIABETES (2013)
Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis
Christopher Savard et al.
HEPATOLOGY (2013)
The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
Marno C. Ryan et al.
JOURNAL OF HEPATOLOGY (2013)
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
Derrick M. Van Rooyen et al.
JOURNAL OF HEPATOLOGY (2013)
NAFLD in Asia-as common and important as in the West
Geoffrey C. Farrell et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Liver cholesterol: is it playing possum in NASH?
Geoffrey C. Farrell et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Increased Hepatic Synthesis and Dysregulation of Cholesterol Metabolism Is Associated with the Severity of Nonalcoholic Fatty Liver Disease
Hae-Ki Min et al.
CELL METABOLISM (2012)
Non-High-Density Lipoprotein Cholesterol as a Biomarker for Nonalcoholic Steatohepatitis
Kathleen E. Corey et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2012)
Atorvastatin improves disease activity of nonalcoholic steatohepatitis partly through its tumour necrosis factor-α-lowering property
Hideyuki Hyogo et al.
DIGESTIVE AND LIVER DISEASE (2012)
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
Naga Chalasani et al.
HEPATOLOGY (2012)
Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up
Shira Zelber-Sagi et al.
JOURNAL OF HEPATOLOGY (2012)
Are Dietary Cholesterol Intake and Serum Cholesterol Levels Related to Nonalcoholic Fatty Liver Disease in Obese Children?
Dimitrios Papandreou et al.
CHOLESTEROL (2012)
Nutrition and Nonalcoholic Fatty Liver Disease: The Significance of Cholesterol
Munechika Enjoji et al.
INTERNATIONAL JOURNAL OF HEPATOLOGY (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Physical Activity Recommendations, Exercise Intensity, and Histological Severity of Nonalcoholic Fatty Liver Disease
Kristin D. Kistler et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
Derrick M. van Rooyen et al.
GASTROENTEROLOGY (2011)
Prevalence of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis Among a Largely Middle-Aged Population Utilizing Ultrasound and Liver Biopsy: A Prospective Study
Christopher D. Williams et al.
GASTROENTEROLOGY (2011)
Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
Hyohun Park et al.
JOURNAL OF GASTROENTEROLOGY (2011)
Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity
Piia Simonen et al.
JOURNAL OF HEPATOLOGY (2011)
Nonalcoholic Fatty Liver Disease: Focus on Lipoprotein and Lipid Deregulation
Klementina Fon Tacer et al.
JOURNAL OF LIPIDS (2011)
Increased Arterial Stiffness and Impaired Endothelial Function in Nonalcoholic Fatty Liver Disease: A Pilot Study
Charalambos Vlachopoulos et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
Functional and Morphological Vascular Changes in Pediatric Nonalcoholic Fatty Liver Disease
Lucia Pacifico et al.
HEPATOLOGY (2010)
Fatty Liver is Associated With Dyslipidemia and Dysglycemia Independent of Visceral Fat: The Framingham Heart Study
Elizabeth K. Speliotes et al.
HEPATOLOGY (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Efficacy of ezetimibe for the treatment of non-alcoholic steatohepatitis: An open-label, pilot study
Masato Yoneda et al.
HEPATOLOGY RESEARCH (2010)
Atorvastatin decreases serum levels of advanced glycation endproducts (AGEs) in nonalcoholic steatohepatitis (NASH) patients with dyslipidemia: clinical usefulness of AGEs as a biomarker for the attenuation of NASH
Yuki Kimura et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis
Vasilios G. Athyros et al.
LANCET (2010)
Diagnostic Value of a Computerized Hepatorenal Index for Sonographic Quantification of Liver Steatosis
Muriel Webb et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2009)
Dysfunctional Very-Low-Density Lipoprotein Synthesis and Release Is a Key Factor in Nonalcoholic Steatohepatitis Pathogenesis
Koji Fujita et al.
HEPATOLOGY (2009)
Association Between Dietary Nutrient Composition and the Incidence of Cirrhosis or Liver Cancer in the United States Population
George N. Ioannou et al.
HEPATOLOGY (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with 1H magnetic resonance spectroscopy
Marcello Mancini et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2009)
Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: The significance of dietary cholesterol
Kenichiro Yasutake et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis
Kristiaan Wouters et al.
HEPATOLOGY (2008)
Incidence and natural course of fatty liver in the general population: the dionysos study
Giorgio Bedogni et al.
HEPATOLOGY (2007)
Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet
Naoto Matsuzawa et al.
HEPATOLOGY (2007)
A lipidomic analysis of nonalcoholic fatty liver disease
Puneet Puri et al.
HEPATOLOGY (2007)
NAFLD and hyperinsulinemia are major determinants of serum ferritin levels
Shira Zelber-Sagi et al.
JOURNAL OF HEPATOLOGY (2007)
Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis
Kanji Yamaguchi et al.
HEPATOLOGY (2007)
Mitochondrial free cholesterol loading sensitizes to TNF- and Fas-mediated steatohepatitis
Montserrat Mari et al.
CELL METABOLISM (2006)
The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
M Hamaguchi et al.
ANNALS OF INTERNAL MEDICINE (2005)
Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver
GX Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The liver X receptor gene team: Potential new players in atherosclerosis
JJ Repa et al.
NATURE MEDICINE (2002)
Fatty liver in non-alcoholic non-overweight Japanese adults: Incidence and clinical characteristics
K Omagari et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Role of LXRs in control of lipogenesis
JR Schultz et al.
GENES & DEVELOPMENT (2000)
Share Paper
